M A Tikhonova Selected Research

Imipramine (Janimine)

6/2016	Effect of Antidepressants on Immunological Reactivity in ASC Mice with Genetically Determined Depression-Like State.
1/2015	[Comparison of behavioral effects of fluoxetine, imipramine and new psychotropic drug TC-2153 on mice with hereditary predisposition to catalepsy].
9/2010	[Effects of chronic imipramine treatment on behavior in mice of congenic strains AKR and AKR.CBA-D13Mit76 differing in the distal fragment of chromosome 13].
5/2009	Chronic administration of imipramine normalizes decreased sexual motivation and increased predisposition to catalepsy induced by propylthiouracil in rats.
3/2008	[Chronic imipramine treatment normalizes decreased sexual motivation and high predisposition to catalepsy induced by propylthiouracil in rat].
1/2006	Effect of imipramine on the behavior and cerebral 5-HT1A serotonin receptors in mice genetically predisposed to catalepsy.
10/2004	Chronic administration of imipramine decreases freezing time in rats genetically predisposed to catalepsy.
8/2002	Effect of chronic administration of imipramine on 2A-serotonin receptor mRNA in brain cortex of rats predisposed and resistant to catalepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M A Tikhonova Research Topics

Disease

17	Catalepsy 01/2015 - 08/2002
4	Genetic Predisposition to Disease (Genetic Predisposition) 06/2016 - 12/2009
4	Pulmonary Tuberculosis 01/2007 - 01/2002
2	Body Weight (Weight, Body) 05/2009 - 03/2008
1	Parkinson Disease (Parkinson's Disease) 08/2021
1	Neoplasms (Cancer) 03/2021
1	Chronic Disease (Chronic Diseases) 03/2021
1	Mental Disorders (Mental Disorder) 07/2012
1	Cysts 04/2007
1	Wounds and Injuries (Trauma) 04/2007
1	Spinal Cord Injuries (Spinal Cord Injury) 04/2007
1	Glioma (Gliomas) 04/2007
1	Infections 01/2007
1	Tuberculosis (Tuberculoses) 01/2006
1	Sepsis (Septicemia) 01/2002

Drug/Important Bio-Agent (IBA)

9	Antidepressive Agents (Antidepressants)IBA 06/2016 - 03/2008
8	Imipramine (Janimine)FDA LinkGeneric 06/2016 - 08/2002
4	Fluoxetine (Prozac)FDA LinkGeneric 06/2016 - 03/2009
4	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2009 - 04/2004
4	Propylthiouracil FDA Link 05/2009 - 04/2004
2	Messenger RNA (mRNA)IBA 05/2013 - 08/2002
2	Serotonin (5 Hydroxytryptamine)IBA 09/2012 - 03/2011
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2012 - 12/2009
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 09/2010 - 05/2009
2	Serotonin ReceptorsIBA 06/2010 - 01/2006
2	Interferon-alpha (Interferon Alfa)IBA 04/2007 - 01/2007
2	Tuberculin (PPD)IBA 01/2007 - 01/2004
2	AntigensIBA 01/2007 - 01/2002
2	Hormones (Hormone)IBA 09/2005 - 04/2004
2	Thyroid HormonesIBA 09/2005 - 04/2004
1	Sirolimus (Rapamycin)FDA Link 08/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2021
1	TrehaloseIBA 08/2021
1	AntioxidantsIBA 03/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2021
1	Anthocyanins (Anthocyanin)IBA 03/2021
1	8- (trifluoromethyl)- 1,2,3,4,5- benzopentathiepin- 6- amineIBA 01/2015
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 05/2013
1	CorticosteroneIBA 09/2012
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 07/2012
1	Pharmaceutical PreparationsIBA 03/2011
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2010
1	InterferonsIBA 01/2007
1	N 30IBA 01/2007
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2007
1	Interleukin-2 (IL2)IBA 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006
1	Interleukin-10 (Interleukin 10)IBA 01/2006
1	Biological ProductsIBA 01/2002
1	CytokinesIBA 01/2002

Therapy/Procedure

4	Therapeutics 04/2007 - 01/2002
1	Immunotherapy 04/2007
1	Transplantation 04/2007